These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6125189)

  • 21. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indomethacin and propranolol combined treatment for Shy-Drager syndrome.
    Galassi G
    J Neurol Neurosurg Psychiatry; 1982 May; 45(5):472-3. PubMed ID: 7086460
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of xamoterol in a patient with idiopathic autonomic failure.
    Elizabeth J; Solomon LR; Lye M
    J Auton Nerv Syst; 1992 Apr; 38(1):65-8. PubMed ID: 1350286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of idiopathic orthostatic hypotension with xamoterol.
    Yamashita H; Yahara O; Hasebe N; Kawamura Y; Obara A; Honda H; Kimura T; Onodera S
    Lancet; 1987 Jun; 1(8547):1431-2. PubMed ID: 2884518
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of prenalterol on orthostatic hypotension in the Shy-Drager syndrome.
    Goovaerts J; Verfaillie C; Fagard R; Knockaert D
    Br Med J (Clin Res Ed); 1984 Mar; 288(6420):817-8. PubMed ID: 6142747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome.
    Schirger A; Sheps SG; Thomas JE; Fealey RD
    Mayo Clin Proc; 1981 Jul; 56(7):429-33. PubMed ID: 6166817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced survival after isoprenaline/dopamine in d,l-propranolol intoxicated rats.
    Toet AE; te Biesebeek JD; Vleeming W; Wemer J; Meulenbelt J; de Wildt DJ
    Hum Exp Toxicol; 1996 Feb; 15(2):120-8. PubMed ID: 8645502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease in beta-receptor density explaining the development of pindolol- and prenalterol-tolerance in orthostatic hypotension.
    Andersen EB; Lindskov HO; Marving J; Boesen F; Beck-Nielsen H; Hesse B
    Dan Med Bull; 1985 Jun; 32(3):194-6. PubMed ID: 2861975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-adrenoceptor blockade and psychic stress in man. A comparison of the acute effects of labetalol, metoprolol, pindolol and propranolol on plasma levels of adrenaline and noradrenaline.
    Trap-Jensen J; Carlsen JE; Hartling OJ; Svendsen TL; Tangø M; Christensen NJ
    Br J Clin Pharmacol; 1982; 13(Suppl 2):391S-395S. PubMed ID: 6125191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of autonomic neuropathy, postural tachycardia and orthostatic syncope with octreotide LAR.
    Hoeldtke RD; Bryner KD; Hoeldtke ME; Hobbs G
    Clin Auton Res; 2007 Dec; 17(6):334-40. PubMed ID: 17767379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
    Sznajderman M; Cybulska I; Niegowska J; Zawadzki Z; Sznajderman M
    Kardiol Pol; 1985; 28(7):489-99. PubMed ID: 2868145
    [No Abstract]   [Full Text] [Related]  

  • 33. Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?
    McDevitt DG
    Drugs; 1983 Apr; 25(4):331-8. PubMed ID: 6133735
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of beta receptor blockaders in orthostatic dysregulation in a critical study and following long-term therapy].
    Weidinger P; Steinbach K
    Fortschr Med; 1973 Apr; 91(10):447-54. PubMed ID: 4144749
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of propranolol in the treatment of idiopathic orthostatic hypotension.
    Chobanian AV; Volicer L; Liang CS; Kershaw G; Tifft C
    Trans Assoc Am Physicians; 1977; 90():324-34. PubMed ID: 611664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-adrenergic blocking therapy in hypertension: selection of patients.
    Frohlich ED; Tarazi RC; Dustan HP
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):151-6. PubMed ID: 4395481
    [No Abstract]   [Full Text] [Related]  

  • 37. Metoprolol-induced changes in myocardial (123)I-metaiodobenzylguanidine uptake in Parkinson's disease.
    de Milliano PA; van Eck-Smit BL; de Groot AC; Lie KI
    Circulation; 2000 Nov; 102(20):2553-4. PubMed ID: 11076832
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta-adrenergic antagonists in the treatment of patients with heart disease.
    Moses JW; Borer JS
    Dis Mon; 1981 Jun; 27(9):1-61. PubMed ID: 6114824
    [No Abstract]   [Full Text] [Related]  

  • 39. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
    Kirch W; Axthelm T
    Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity on local wall motion abnormalities in patients with coronary heart disease.
    Gleichmann U; Fassbender D; Trieb G; Mannebach H; Ohlmeier H
    Br J Clin Pharmacol; 1982; 13(Suppl 2):301S-304S. PubMed ID: 6125180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.